• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Advances in ovarian cancer, from biology to treatment.

作者信息

McMullen Michelle, Karakasis Katherine, Rottapel Robert, Oza Amit M

机构信息

Division of Medical Oncology & Hematology, Bras Family Drug Development Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

出版信息

Nat Cancer. 2021 Jan;2(1):6-8. doi: 10.1038/s43018-020-00166-5.

DOI:10.1038/s43018-020-00166-5
PMID:35121897
Abstract
摘要

相似文献

1
Advances in ovarian cancer, from biology to treatment.卵巢癌的进展：从生物学到治疗
Nat Cancer. 2021 Jan;2(1):6-8. doi: 10.1038/s43018-020-00166-5.
2
SEOM clinical guideline in ovarian cancer (2020).SEOM 卵巢癌临床实践指南（2020 年）。
Clin Transl Oncol. 2021 May;23(5):961-968. doi: 10.1007/s12094-020-02545-x. Epub 2021 Jan 30.
3
Evolving Concepts in the Management of Newly Diagnosed Epithelial Ovarian Cancer.新诊断上皮性卵巢癌管理中的不断演变的概念
J Clin Oncol. 2019 Sep 20;37(27):2386-2397. doi: 10.1200/JCO.19.00337. Epub 2019 Aug 12.
4
Management of epithelial ovarian cancer.上皮性卵巢癌的管理
Clin Adv Hematol Oncol. 2018 Oct;16(10):656-659.
5
Ovarian Clear Cell Carcinoma: From Morphology to Molecular Biology.卵巢透明细胞癌：从形态学到分子生物学
Appl Immunohistochem Mol Morphol. 2019 Oct;27(9):631-636. doi: 10.1097/PAI.0000000000000662.
6
Treatment of Rare Epithelial Ovarian Tumors.罕见上皮性卵巢肿瘤的治疗
Hematol Oncol Clin North Am. 2018 Dec;32(6):1011-1024. doi: 10.1016/j.hoc.2018.07.015.
7
Risk factors associated with epithelial ovarian cancer in women with endometriosis.子宫内膜异位症女性中与上皮性卵巢癌相关的危险因素。
Taiwan J Obstet Gynecol. 2020 May;59(3):353-355. doi: 10.1016/j.tjog.2020.03.002.
8
Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.上皮性卵巢癌生物标志物检测的建议：西班牙病理学会和西班牙肿瘤内科学会的国家共识声明。
Clin Transl Oncol. 2018 Mar;20(3):274-285. doi: 10.1007/s12094-017-1719-x. Epub 2017 Aug 16.
9
Follow-up of epithelial ovarian cancer: overdue for a major rethink.上皮性卵巢癌的随访：亟待重大反思。
Curr Oncol Rep. 2013 Jun;15(3):204-6. doi: 10.1007/s11912-013-0310-z.
10
[A Retrospective Analysis of Systematic Lymphadenectomy for Loco-Regional(pT1)Epithelial Ovarian Cancer].[局限性（pT1）上皮性卵巢癌系统性淋巴结清扫术的回顾性分析]
Gan To Kagaku Ryoho. 2017 Aug;44(8):681-684.

引用本文的文献

1
Fertility-sparing surgery upon reproductive and oncologic results in ovarian cancer patients stage I (FIGO): a systematic review.I期（国际妇产科联盟）卵巢癌患者保留生育功能手术对生殖及肿瘤学结局的影响：一项系统评价
Arch Gynecol Obstet. 2025 May 23. doi: 10.1007/s00404-025-08062-y.
2
A necrosis inducer promotes an immunogenic response and destroys ovarian cancers in mouse xenografts and patient ascites organoids.一种坏死诱导剂可促进免疫原性反应，并在小鼠异种移植瘤和患者腹水类器官中破坏卵巢癌。
Cancer Lett. 2025 Aug 10;625:217738. doi: 10.1016/j.canlet.2025.217738. Epub 2025 Apr 29.
3
Dual Cas12a and multiplex crRNA CRISPR strategy ultrasensitive detection novel circRNA biomarker for the diagnosis of ovarian cancer.
双Cas12a与多重crRNA CRISPR策略用于超灵敏检测新型环状RNA生物标志物以诊断卵巢癌。
BMC Cancer. 2025 Apr 15;25(1):695. doi: 10.1186/s12885-025-14116-w.
4
PCYT2 mediates ovarian epithelial cancer metastasis by regulating cell membrane fluidity through the AMPK/FOXO1 signalling pathway.PCYT2通过AMPK/FOXO1信号通路调节细胞膜流动性，介导卵巢上皮癌转移。
Sci Rep. 2025 Apr 8;15(1):12044. doi: 10.1038/s41598-025-96405-9.
5
Exploring the effects of paclitaxel-loaded zein nanoparticles on human ovarian carcinoma cells.探索载有紫杉醇的玉米醇溶蛋白纳米颗粒对人卵巢癌细胞的影响。
Sci Rep. 2025 Mar 27;15(1):10553. doi: 10.1038/s41598-025-90840-4.
6
KPNA5 Suppresses Malignant Progression of Ovarian Cancer Through Importing the PTPN4 Into the Nucleus.KPNA5通过将PTPN4导入细胞核来抑制卵巢癌的恶性进展。
Cancer Med. 2025 Apr;14(7):e70731. doi: 10.1002/cam4.70731.
7
Risk factors for anastomotic leakage and its impact on survival outcomes in radical multivisceral surgery for advanced ovarian cancer: an AGO-OVAR.OP3/LION exploratory analysis.晚期卵巢癌根治性多脏器手术中吻合口漏的危险因素及其对生存结局的影响：AGO-OVAR.OP3/LION探索性分析
Int J Surg. 2025 Apr 1;111(4):2914-2922. doi: 10.1097/JS9.0000000000002306.
8
PLIN2 Promotes Lipid Accumulation in Ascites-Associated Macrophages and Ovarian Cancer Progression by HIF1α/SPP1 Signaling.PLIN2通过HIF1α/SPP1信号通路促进腹水相关巨噬细胞中的脂质积累和卵巢癌进展。
Adv Sci (Weinh). 2025 Mar;12(12):e2411314. doi: 10.1002/advs.202411314. Epub 2025 Feb 7.
9
Bola-Amphiphilic Dendrimer Enhances Imatinib to Target Metastatic Ovarian Cancer via β-Catenin-HRP2 Signaling Axis.bola-两亲性树枝状大分子通过β-连环蛋白-HRP2信号轴增强伊马替尼对转移性卵巢癌的靶向作用。
ACS Appl Mater Interfaces. 2025 Jan 15;17(2):2884-2898. doi: 10.1021/acsami.4c12857. Epub 2025 Jan 3.
10
The CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells.CXCR4拮抗剂R54靶向人卵巢癌细胞中的上皮-间质转化（EMT）。
PLoS One. 2024 Dec 19;19(12):e0314735. doi: 10.1371/journal.pone.0314735. eCollection 2024.